| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
NEUROENDOCRINOLOGY |
Center for Human Molecular Genetics and Department of Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska 68198-5455
Address all correspondence and requests for reprints to: Mark Y. J. Ma, Center for Human Molecular Genetics and Department of Cell Biology and Anatomy, 985455 University of Nebraska Medical Center, Omaha, Nebraska 68198-5455. E-mail: yma{at}unmc.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Although the importance of neuronal control on the activity of LHRH neurons is obvious, studies of immature female rats have provided new evidence that hypothalamic astroglial cells actively interact with LHRH neurons (for review see Ref. 14). This cross-talk between astroglia and LHRH neurons is important for the activation of LHRH release that leads to the onset of female puberty. The regulatory signaling events of astroglia are mediated by membrane-anchored ErbB tyrosine kinase receptors that belong to the epidermal growth factor receptor family (14). For instance, activation of ErbB-1 receptors in hypothalamic astrocytes by TGF
of astrocytic origin results in the production of PGE2, which consequently stimulates the release of LHRH, leading to the onset of mammalian female puberty (15). It is further demonstrated that induction of ErbB-1-mediated signaling events by TGF in the hypothalami of transgenic mice (16) or mice grafted with genetically engineered TGF-producing cells (17) results in an enhanced LHRH release. This, in turn, leads to acceleration of sexual maturation. Conversely, blockade of ErbB-1-mediated signal transduction delays the onset of puberty due to the reduction of LHRH release (18, 19).
It is clear that activation of ErbB-1 in hypothalamic astroglial cells contributes to the initiation of mammalian female puberty by the stimulation of LHRH secretion. This view is also supported by the finding that activation of ErbB-1 receptors by TGF occurs during the onset of puberty in rhesus monkeys (20, 21). Little is known, however, about potential roles of this and other related receptors in the maintenance of reproduction during adulthood. This is a critical issue because it is relevant to the possibility that altered capacity of the ErbB receptor signaling system may contribute to estrous acyclicity in reproductive aging females. The present study was undertaken to examine the hypothesis that age-related changes in ErbB-1 gene function may be linked to altered cyclicity in aging female rats. Semiquantitative RT-PCR and Western blot analyses were used to examine the expression of hypothalamic ErbB-1 from young adult and aging females. In situ hybridization histochemistry was also employed to examine expression of ErbB-1 mRNA in the hypothalamus during proestrus of the estrous cycle. As shown here, ErbB-1 is expressed in the hypothalamic areas related to control of LHRH release. Age-related changes in ErbB-1 receptor expression occur in aging female rats and may be linked to altered gonadotropin release. Importantly, blockade of ErbB-1 receptor-mediated signal transduction via a highly specific ErbB-1 inhibitor resulted in disruption of estrous cyclicity in adult female rats.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Every experiment was performed in compliance with guidelines on the use of laboratory and experimental animals. The protocols used were approved by our institutional animal care and use committee at University of Nebraska Medical Center (protocol 99-055-00).
Tissue dissection and RNA isolation
Immediately after decapitation, brains were removed, and two major parts were dissected from the hypothalamus as described previously (22). Briefly, one is the preoptic area (POA; 
2 mm thick) comprising the region dorsal and anterior to the optic chiasm. The POA was collected by a coronal cut just posterior to the entry point of the optic chiasm and two cuts converging from the lateral edges of the optic chiasm to a point rostral to the decussation of the optic nerves. The second consists of the medial basal hypothalamic area that includes the ME-arcuate region (ME-ARC; 2 mm thick). The ME-ARC was dissected by a coronal cut at the rostral border of the mammillary body and one sagittal cut halfway between the ME and the hypothalamic sulci on each side. A site on the anterior region of cortex was also collected to serve as a control tissue. All collected tissues were immediately stored at -80 C until RNA extraction. Total RNA was isolated by the acid-phenol method (23). Trunk blood was collected and allowed to clot overnight at 4 C, then centrifuged. The supernatant was collected and stored at -20 C until hormone assays.
RT-PCR assay
Oligodeoxynucleotides.
All oligodeoxynucleotides used for PCR were synthesized by MWG-Biotech, Inc. (High Point, NC). An oligonucleotide containing a 15-mer polydeoxythymidine sequence (purchased from Promega Corp., Madison, WI) was used for RT of poly(A) cellular mRNA. An extracellular portion of rat ErbB-1 cDNA (272 bp) was amplified from total RNA derived from the POA, ME-ARC, or cortex using primers corresponding to nucleotides (nt) 311–330 (5'-GGATGTTCAACAACTGTGAA-3') and complementary to nt 563–582 (5'-AATTTCCTGTAAGTTCCGCA-3') (24). Individual sources of variability were accounted for by coamplifying cyclophilin mRNA, which is constitutively expressed in brain (25). In addition, it has been shown that no significant differences in cyclophilin mRNA levels are detectable by reproductive status or age (13, 18). Therefore, cyclophilin was used as an internal control. The cyclophilin primers were 5'-GGCAAGTCCATCTACGGA-3' (corresponding to nt 265–282) and 5'-ACATGCTTGCCATCCAGC-3' (complementary to nt 405–422) (25).
RT-PCR procedures.
The procedures have been described previously in detail (20) with minor modifications. In brief, RT reaction was carried out for 2 h at 37 C in a 20-µl volume. Each reaction mixture contained 200 ng total RNA that was ribonuclease-free and deoxyribonuclease-treated, 1x RT buffer, 0.01 M dithiothreitol, 0.5 mM of each dNTP, and 20 U Moloney murine leukemia virus reverse transcriptase (Life Technologies, Inc., Gaithersburg, MD). PCR was performed in a 25-µl total volume consisting of 2 µl diluted (1 µl RT/1 µl sH20) RT mixture, 2.5 µl of 10x PCR buffer, 4 µl 25 mM MgCl2, 1 µl 10 mM dNTP, 20 pmol of each specific gene primer set including both 5'- and 3'-primers, 5 pmol of each 5'- and 3'-end cyclophilin primer, and 0.625 U Taq polymerase (Promega Corp.). After samples were treated at 94 C for 4 min to inactivate the reverse transcriptase, PCR consisted of 35 cycles of denaturing (95 C, 15 sec), annealing (55 C, 1 min), extension (72 C, 2 min), and a final extension of 7 min at 72 C.
Quantitative analysis
Amplified cDNAs were visualized by electrophoresis where 20 µl of each PCR reaction sample were run on a 3% agarose gel containing ethidium bromide (0.1 µg/ml). The images were captured by photographing on 555 Polaroid film (Cambridge, MA). The photos were scanned for densitometric analysis using Hewlett-Packard Co. ScanJet 6200C flat bed scanner and the computer image program written by Dr. Wayne Rasband (NIH, Bethesda, MD). We used a backgroundsubtracted mean OD to measure each amplified cDNA signal. Mean OD values were normalized according to the coamplified cyclophilin cDNA value detected in each sample. The authenticity of each PCR-amplified product was confirmed by sequencing analysis (22).
Western blot analysis
Tissue samples (four to six ME-ARC or POA fragments per time point) were collected at 1000, 1200, and 1500 h during proestrus and stored at -80 C until preparation of the whole cell lysate using procedures previously described (22). The protein concentration of each lysate was determined using a protein assay kit (Bio-Rad Laboratories, Inc., Hercules, CA). Immunoprecipitation was initiated by adding 10 µl ErbB-1 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) antibody to each sample containing 1 mg protein in a 500-µl volume. Samples were then incubated for 12–14 h at 4 C under constant rotation. Thereafter, 35 µl water-saturated protein A-Sepharose (1:1 slurry) were added to each sample and incubated at 4 C for an additional 4 h with rotation. The immunoprecipitates were pelleted in the microcentrifuge and washed once with 0.5 ml cold RIPA buffer (1% IGEPAL CA-630, 0.5% deoxycholic acid sodium, 0.1% SDS in 1x PBS), 10 µl 10 mg/ml phenylmethylsulfonylfluoride, 5 µl 200x protease inhibitor cocktail (0.952% leupeptin, 1.372% pepstain, and 1.5% aprotinin), and 10 µl 100 mM sodium orthovanadate in 1 ml RIPA before use and twice with 0.5 ml cold 1x PBS (9.1 mM Na2HPO4, 1.7 mM NaH2PO4, and 150 mM NaCl). Immunoprecipitated proteins were electrophoresed on an 8% SDS-polyacrylamide mini-gel and then electrotransferred onto a nitrocellulose membrane (Schleicher \|[amp ]\| Schuell, Inc., Keene, NH) via a transfer apparatus (Bio-Rad Laboratories, Inc.). After electrotransferring, gels were stained with GELCODE Blue Stain Reagent (Pierce Chemical Co., Rockford, IL) to ascertain a complete transfer of protein. The membranes were blocked with 5% nonfat milk and 5% BSA in Tris-buffered saline (TBS)-Tween 20 [0.2% Tween 20, 50 mM Tris (pH 7.4), and 154 mM NaCl] for 3 h at room temperature. Each membrane was probed with a specific primary antibody (1:500 dilution) in TBS-Tween 20 solution containing 2% nonfat milk for 2 h at room temperature with gentle agitation. Membranes were then washed eight times for 8 min each time with TBS-Tween 20 at room temperature, followed by probing with an antispecies-specific horseradish peroxidase-linked antibody (1:2000 in TBS-Tween 20) for 1 h with gentle agitation. After washing again as described above, target protein signals were detected using the SuperSignal chemiluminescence system (Pierce Chemical Co.).
In situ hybridization histochemistry
Animals were cardially perfused with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. The brains were dissected out and further fixed with the same fixative for 24 h at 4 C. Thereafter, the fixative was replaced with cold (4 C) 25% sucrose in 0.1 M phosphate butter (pH 7.4). After 24 h, the brains were transferred into new sucrose solution for an additional 1 or 2 d at 4 C. The brains were then blocked and stored at -80 C until being coronally sectioned at 20 µm using a freeze sliding microtome. The sections were then mounted on gelatin-coated SuperFrost glass slides (Fisher Scientific, Pittsburgh, PA) and allowed to dry overnight in a vacuum hood. The dried slides were stored in slide boxes at -85 C before hybridization.
Probe preparation
To prepare the [35S]UTP-labeled ErbB-1 riboprobe, DNA templates corresponding to sequences contained in the coding region of ErbB-1 mRNA as previously reported (22) were used. Briefly, it recognizes the extracellular domain of the full-length ErbB-1 mRNA and its 3'-end of the truncated form. The cRNA probe was synthesized by in vitro transcription using T7 polymerase.
Prehybridization, hybridization, and posthybridization
The procedures were followed as previously described (26). In short, each slide was overlaid with 180 µl hybridization solution containing 50% deionized formamide, 4x SSC, 1x Denhardt’s solution, 0.5 mg/ml salmon sperm DNA, 0.25 mg/ml tRNA, 10% dextran sulfate, and the riboprobe of interest (5–10 x 106 cpm/ml). The slides were hybridized in a slide moat (model 240000, Boekel Scientific, Feasterville, PA) for 16–20 h at 56 C. Posthybridization procedures were performed as previously reported (26). After dehydration in graded alcohols, the slides were dipped in NTB3 emulsion (catalogue 1654441, Kodak, Rochester, NY) and developed after 2 wk of exposure. All slides were stained with Toluidine Blue O (Fisher Scientific, catalog no. T-161). Control sections were hybridized with a sense RNA probe.
Hormone assays
Plasma levels of LH were measured using enzyme immunoassay (EIA) detection kit (code RPN 2562) purchased from Amersham Pharmacia Biotech (Piscataway, NJ). The sensitivity of the assay was 0.1 ng/ml, and intraassay coefficients of variation were 7.6%. Circulating E2 and progesterone (P4) concentrations were determined by EIA detection kits [catalogue DE2000 (E2), R\|[amp ]\|D Systems, Inc., Minneapolis, MN; 07B70102A (P4), ICN Pharmaceuticals, Inc., Orangeburg, NY]. The lowest detectable levels of E2 and P4 were 10.1 pg/ml and 0.05 ng/ml, respectively.
ErbB-1 receptor tyrosine kinase inhibitor treatment
To block signal transduction mediated by the ErbB-1 receptor, AG-1478 (provided by Dr. Alexander Levitzki, Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel), a quinazoline potent inhibitor of ErbB-1 tyrosine kinase (27, 28), was administered to 50- to 60-d-old YA female rats displaying at least two consecutive estrous cycles. Each rat was ip injected on the diestrous d 2 (1500 h), followed by two injections the next day (proestrus), at 1000 and 1500 h, respectively. The dosage used (50 mg/kg BW) was based on the findings that ErbB-1 tyrosine kinase activity was effectively inhibited in vivo at this concentration (28). The AG-1478 compound was dissolved in dimethylsulfoxide (DMSO; 100 mg/ml) before injection. Age-matched control animals were treated with no injection, DMSO as a vehicle, and AG-825 (BIOMOL Research Laboratories, Inc., Plymouth Meeting, PA), which is structurally similar to AG-1478, but not active in vivo (29).
Statistical analyses
Comparisons of changes in ErbB-1 mRNA and all hormonal levels were analyzed by two-way ANOVA, followed by Student-Newman-Keuls multiple comparison test for unequal replications. In all cases, significance was set at P < 0.05.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
. Expression of ErbB-1 mRNA in the POA is low for both YA and MA rats in early morning (0600–0800 h) of the proestrous day. ErbB-1 gene expression significantly increases in YA rats at 1000 h and reaches a maximal level at 1500 h (Fig. 2A). In contrast, no initial elevation at 1000 h was found in MA animals (Fig. 2A). Although the level of ErbB-1 mRNA increases at 1500 h in MA rats, it is not statistically significant compared with that at other time points. Importantly, this elevation is significantly lower than that in YA animals (Fig. 2A). In YA animals, ErbB-1 mRNA expression levels in the ME-ARC are high during the early morning of the proestrous day, reach a maximal value at 0800 h, then decrease significantly to low levels during the afternoon (Fig. 2B). In comparison to YA rats, ErbB-1 mRNA levels in MA animals are lower in the morning and slowly increase to the peak level 4 h later (Fig. 2B). The levels then significantly decrease during the late afternoon. This gene expression pattern in YA animals and the differences in ErbB-1 receptor expression between YA and MA female rats appear to be limited to these specific regions of the hypothalamus. No such expression pattern and differences were observed in the region of cerebral cortex used (not shown), an brain area that has no known involvement in neuroendocrine function.
|
|
, a). Labeled cells are also observed in the ventral region of the medial preoptic area (MPA) and the wall of the third ventricle (Fig. 3, C, c1 and c2). In striking contrast, only a few weakly labeled cells are detected in the matched areas of MA animals (Fig. 3, B, b; D, d1 and d2; Table 1
). These observations further confirm the results detected by RT-PCR. In the medial basal hypothalamus, numerous ErbB-1 mRNA positive cells are found in the ventral-lateral region of the ARC (Fig. 4C, c), which is involved in controlling LHRH release. Interestingly, intensely labeled cells are also identified around the subfornical organ (Fig. 4A, a), the area related to the regulation of water intake (30). A weaker hybridization signal is detected in the dorsal part of the paraventricular thalamic nucleus anterior part (Fig. 4B, b).
|
|
|
). In contrast, no difference was observed in the protein levels of the ME-ARC at 1000 or 1500 h between YA and MA rats (Fig. 5B). However, at 1200 h the ErbB-1 protein level in MA animals was higher than that in YA rats (Fig. 5B). It is clear that ErbB-1 protein expression profiles parallel its gene expression pattern at these three time points. A major reason for selecting only three time points during proestrus was based on the ErbB-1 receptor mRNA expression profile described above. Specifically, mRNA in the ME-ARC of YA rats reached a maximal level at 0800 h, but in MA animals the peak level of ErbB-1 mRNA was found 4 h later. It is thus reasonable to select time points after 0800 h. The 1500-h point was selected because ErbB-1 mRNA levels at this time reached the highest value in the POA. Although it would represent a more accurate protein expression profile if more time points were included, it would be too costly due to the limited protein content that can be obtained from each POA or ME-ARC tissue fragment. This also contributes to the use of four to six pooled tissue fragments per measured time point. Nonetheless, it is clear that the protein expression profiles for both YA and MA animals are comparable to its encoding gene expression pattern.
|
). Furthermore, this difference in LH secretion was probably not due to differential ovarian function, because no significant difference in the levels of E2 and P4 was found between these two age groups (Table 2
).
|
|
). Among the five treated animals, three displayed prolonged diestrus and two exhibited prolonged estrus. In contrast, there was no impact on the cyclicity in the age-matched female rats treated with no injection, AG-825 (structurally similar to AG-1478, but inactive in vivo), or DMSO as a vehicle (Fig. 7).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Hypothalamic cellular localization of ErbB-1 mRNA in YA and MA female rats was determined employing in situ hybridization histochemistry. The results reveal that numerous ErbB-1 mRNA-labeled cells in YA female rats are observed around the OVLT area, a site scattered with LHRH cell bodies (32). This strong expression of ErbB-1 mRNA in the OVLT is consistent with high levels of ErbB-1 protein found in the same area (22). Because ErbB-1 mRNA is mostly expressed in astroglia, but not in LHRH neurons in the hypothalamus (22), these ErbB-1 mRNA-positive cells are probably astroglia. Based on the idea that ErbB-1 receptor-mediated stimulation of LHRH release in pubertal rats requires glial cells (14), it is possible that control of LHRH neuronal function by ErbB-1 receptors in adult females is also dependent at least in part on glial intermediacy. Furthermore, in YA female rats, ErbB-1 mRNA-positive cells are found in the MPA, which is known to be involved in maintenance of estrous cyclicity via control of LHRH release (33). Consistent with the previous study (22), cells scattered along the wall of the third ventricle from YA animals are also ErbB-1 mRNA positive. It is important to note that differences in cellular ErbB-1 mRNA expression in the POA of YA and MA female rats at 1200 h on proestrus were also examined. This time point was selected because ErbB-1 mRNA expression levels detected by RT-PCR (see below) were significantly different between the two age groups. Similar to the RT-PCR results, MA female rats have fewer weakly labeled ErbB-1 mRNA cells in the OVLT, MPA, and wall of third ventricle compared with the matched areas of YA animals.
ErbB-1 mRNA-positive cells are also detected in the medial basal hypothalamus, predominantly in the medial- and ventral-lateral portion of the ARC, which is known to be involved in the regulation of LHRH release (3, 34). This suggests that expression of the ErbB-1 receptor in the ARC may be functionally linked to controlling LHRH secretion. This view is supported by the evidence that activation of ErbB-1 receptors from the ME-ARC results in the release of LHRH (16, 31). Once again, studies have established the concept that the effect of ErbB-1 receptor activation on LHRH release is not exerted directly; instead, intermediate astroglial cells are required (14). ErbB-1 mRNA expressed in the ME-ARC in this study is overlapped with receptor expression found in astroglial cells of the same region in prepubertal rats (22). It is thus plausible that the effect of activation of the ErbB-1 receptor on LHRH release in adult female rats is mediated via astroglial cells. Interestingly, strong ErbB-1 mRNA signals are also detected around the subfornical organ, which is known to be involved in the control of water intake. ErbB-1 mRNA hybridization signals can be identified in the dorsal and lateral edges of the paraventricular thalamic nucleus anterior part. At present, the physiological relevance of ErbB-1 expression in these regions related to reproductive function remains unknown.
Evidence exits that an increase in ErbB-1 gene expression before and during the onset of puberty is necessary for stimulation of LHRH release, which is a key regulator of sexual maturation and reproduction. Thus, alteration in this receptor gene activity may contribute to changes in LHRH neuronal function, which, in turn, lead to the altered gonadotropin output found in aging females (35, 36). This study shows that in the POA of cycling YA rats, ErbB-1 mRNA expression starts to increase during the late morning when serum levels of E2 are high. It then reaches a maximal value at 1500 h, 3 h before the preovulatory LH surge. On the other hand, MA rats show no initial morning or late afternoon significant increase in ErbB-1 mRNA expression. Although there is an increase in mRNA levels at 1500 h, it is significantly lower than that in YA animals. This difference in mRNA levels is also reflected by higher ErbB-1 protein content in YA vs. MA animals. Importantly, these MA animals exhibit no preovulatory-like LH surge at 1800 h on proestrus compared with YA rats, suggesting a delayed LH secretion in these animals. It is well documented that the preovulatory LH surge is either delayed or reduced in MA female rats (37). This indicates that the late afternoon increase in ErbB-1 receptor expression during proestrus may be required for induction of the preovulatory LH surge. This view is supported by evidence that ligand-induced activation of ErbB-1 receptors results in stimulation of LHRH release (16, 17, 31). Conversely, disruption of the ErbB-1 receptor-mediated signal transduction leads to a decrease in LHRH (16) or LH (19) release. Whether the altered ErbB-1 receptor expression in MA rats is causally associated with the decreased or delayed release of gonadotropins found in aging female rats (35, 36) requires further studies. Furthermore, the lack of initial increase in ErbB-1 receptor expression in MA rats, which did not exhibit an LH surge at 1800 h, may be linked to the blunted elevation of receptor expression at 1500 h. This suggests that the initial increase in ErbB-1 receptor expression may be required for inducing full capacity expression in the afternoon of the proestrous day, as seen in YA animals. Importantly, induced full capacity receptor expression may be necessary for the preovulatory gonadotropin release. More studies are needed to address this issue. Interestingly, although a similar peak level of ErbB-1 mRNA in the ME-ARC is found in both proestrous YA and MA animals, it is observed at 0800 h in YA rats, but at 1200 h in MA rats. This time-postponed activation of the ErbB-1 gene in MA rats is temporally comparable to the delayed LHRH and LH release from aging animals (35, 36). These results suggest that temporally regulated activation of ErbB-1 receptors in the hypothalamus may be necessary for induction of the preovulatory release of LHRH, which leads to gonadotropin secretion. Moreover, an intriguing finding in this study is that ErbB-1 expression in the POA of YA animals is temporally different from that in the ME-ARC. In other words, expression levels in the POA start to increase from 1000–1500 h, 3 h before the LH surge. However, ErbB-1 expression levels in the ME-ARC reach the highest value at 0800 h and decrease thereafter. This difference in ErbB-1 gene activity may be required, as one of the regulatory components, for the complexity of temporal and regional control of LHRH neuronal activity. Desynchronization of this component would result in disruption of an integral control of LHRH/LH release, which leads to compromised female reproduction during aging.
Activation of ErbB-1 receptors is a key step for initiating downstream signaling (38). Targeted inhibition of this receptor tyrosine kinase activity by tyrphostins (27) has been employed to study the role of ErbB-1 receptors in different cellular systems, i.e. suppression of tumorigenesis (28), inhibition of LHRH secretion ( 31), and, consequently, blockade of female sexual maturation (18). A tyrphostin named AG-1478 was selected to examine whether the blockade of ErbB-1 receptors would result in disruption of estrous cyclicity. This tyrphostin compound is highly specific to the ErbB-1 receptor and can inhibit ligand-induced kinase autophosphorylation at a low nanomolar range in vivo (27). The results clearly show that acute administration of AG-1478 to cycling YA female rats indeed disrupts the estrous cycle. Those animals treated with the blocker exhibited either prolonged diestrus or prolonged estrus, which is a typical estrous cycle displayed by MA female rats. The effect of AG-1478 appears to be specific, as no such effect was observed in animals treated with AG-825, which is an inactive tyrphostin in vivo (29). Moreover, the disruption of estrous cyclicity was short term and fully reversible after one cycle disruption. This result is consistent with a short half-life (31 min) of AG-1478 when it is used in vivo (28). The number of proestrus followed by estrus and diestrus was used to determine the number of estrous cycles. Although pharmocological study supports the specificity of AG-1478, it cannot be completely ruled out that this compound could inhibit other tyrosine kinases if administered at a relatively high concentration. However, this may not be the case in the current study because 1) the dosage of AG-1478 used is the same as in a previous study (28), in which the researchers reported a peak plasma concentration of 61 µM after a single ip injection; 2) one injection is not enough to produce the level (>100 µM) required to inhibit other tyrosine kinase receptors, such as ErbB-2 or platelet-derived growth factor receptor (27); and 3) the two injections administered with a 5-h gap on the day of proestrus are unlikely to produce a 100-µM plasma level of AG-1478, as only 1.5 µM can be detected within 4 h after a single injection (28). Thus, the impact of AG-1478 on estrous cyclicity is probably due to inhibition of ErbB-1-mediated signal transduction. Although the lipophilic nature of AG-1478 ensures its action on the central nervous system, particularly the hypothalamus, we cannot rule out its action on other peripheral tissues, such as ovaries. However, this is unlikely, because activation of ErbB-1 in ovaries results in the blockade of ovulation (16). Nevertheless, it is clear that ErbB-1 receptors are important for maintaining normal estrous cyclicity. This view is supported by a recent study (19) that demonstrates that the estrous cycle is significantly altered in ErbB-1-defected Wa-2 mutants. Moreover, by employing transgenic animals carrying a transgene that encodes functionally defected ErbB-1 mutant receptors that are capable of interrupting normal ErbB-1 receptor signaling activity only in astroglial cells, the estrous cyclicity of transgenic female mice is disrupted (our unpublished observation). It is important to note that other related tyrosine kinases may contribute to the regulation of female reproduction. Emerging evidence shows that cellular signal transduction mediated by multi-tyrosine kinase receptors is a common feature related to controlling neuroendocrine function. For instance, the insulin receptor (39) and IGF receptor (19) are also necessary for maintaining normal reproduction.
In summary, this study demonstrates that blockade of ErbB-1 receptor-mediated signal transduction results in disruption of the estrous cycle. Therefore, the ErbB-1 signaling system is a physiological component necessary for maintaining female reproductive function. The present study also provides evidence that altered ErbB-1 receptor expression in the hypothalamus of aging female rats may be linked to changes in LHRH neuronal activities that lead to attenuated or delayed preovulatory LH surge during reproductive aging.
|
Footnotes |
|---|
Abbreviations: DMSO, Dimethylsulfoxide; EIA, enzyme immunoassay; LHRH, LH-releasing hormone; MA, middle-aged; ME-ARC, median eminence-arcuate nucleus; MPA, medial preoptic area; nt, nucleotides; OVLT, organum vasculosum of the lamina terminalis; P4, progesterone; POA, preoptic area; YA, young adult.
Received July 6, 2001.
Accepted for publication October 15, 2001.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
(TGF) gene expression in astrocytes of the neuroendocrine brain. J Neurosci 14:5644–5651[Abstract]
(TGF) transgene reveals a dual antagonistic role of TGF in female sexual development. Endocrinology 135:1392–1400[Abstract]
expression to discrete loci of the neuroendocrine brain induces female sexual precocity. Proc Natl Acad Sci USA 94:2735–2740 (TGF) gene expression in the hypothalamus is developmentally regulated and linked to sexual maturation. Neuron 9:657–670[CrossRef][Medline]
(TGF) and its receptor in the hypothalamus of female rhesus macaques. Neuroendocrinology 60:346–359[Medline]
bigenic mice. Proc Natl Acad Sci USA 97:9609–9614 in the release of luteinizing hormone-releasing hormone from the developing female hypothalamus. Proc Natl Acad Sci USA 87:9698–9702This article has been cited by other articles:
 |
|
 |
|
  V. Rajagopalan, I. H. Zucker, J. A. Jones, M. Carlson, and Y. J. Ma Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H543 - H554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Li, Z. Yang, J. Hou, A. McCracken, M. A. Jennings, and M. Y. J. Ma Compromised Reproductive Function in Adult Female Mice Selectively Expressing Mutant ErbB-1 Tyrosine Kinase Receptors in Astroglia Mol. Endocrinol., November 1, 2003; 17(11): 2365 - 2376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hou, B. Li, Z. Yang, N. Fager, and M. Y. J. Ma Functional Integrity of ErbB-4/-2 Tyrosine Kinase Receptor Complex in the Hypothalamus Is Required for Maintaining Normal Reproduction in Young Adult Female Rats Endocrinology, May 1, 2002; 143(5): 1901 - 1912. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
